Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neovasc Medical Ltd.

Division of Neovasc Inc.
www.neovasc.com

Latest From Neovasc Medical Ltd.

Neovasc’s Reducer Shows Promise For Refractory Angina

In a small but sham-controlled trial Neovasc’s balloon-expandable implant significantly improved symptoms and quality of life in patients with refractory angina who are not candidates for other revascularization procedures. Reducer works by increasing pressure in the coronary sinus.

Could Pharma's Appetite Spill Over To Devices?

Mergers and acquisitions, once the tried-and-true method of exits for device investors, are now being dominated by Big Pharma. But can this appetite benefit device investors?
Business Strategies

Start-Up Previews (03/07)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group: Do-It-Yourself Dermatology, features profiles of Therative and Xthetix. Plus these Start-Ups Across Health Care: iCardiac Technologies, Jenken Biosciences, Neovasc Medical, and Syntaxin.

Neovasc Medical Ltd.

Neovasc Medical intends to provide a solution for the millions of patients that can't benefit from bypass, PCIs and other traditional revascularization techniques. It has developed a minimally invasive procedure in which a stent inserted percutaneously into the coronary sinus partially restricts the flow of blood exiting into the arteries. The blood flows backwards into the heart, retroperfusing the tissue and reducing symptoms of ischemia.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Neovasc Inc.
  • Senior Management
  • Guy-Charles Fanneau de la Horie, CEO
  • Contact Info
  • Neovasc Medical Ltd.
    Phone: (972) 3634 9990
    6 Yoni Netanyahu St.
    Or Yehuda, 60376
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register